MINNEAPOLIS--(BUSINESS WIRE)--Urologix®, Inc. (NASDAQ:ULGX), today reported financial results for the fiscal 2009 second quarter ended December 31, 2008. Revenue for the second quarter was $3.4 million or 28 percent more than the $2.7 million reported in the first quarter of fiscal year 2009, however it was 11 percent less than the $3.8 million reported in the same period of fiscal 2008. In the second quarter of fiscal 2009, the Company utilized $665,000 of cash and cash equivalents compared to $1.8 million in the first quarter of fiscal 2009, leaving $8.5 million in cash and cash equivalents as of December 31, 2008.
